Colgate-Palmolive Company (CL) Position Maintained by Glenmede Trust Co. NA

Glenmede Trust Co. NA held its stake in Colgate-Palmolive Company (NYSE:CL) during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 756,074 shares of the company’s stock at the end of the 1st quarter. Glenmede Trust Co. NA owned approximately 0.09% of Colgate-Palmolive worth $49,477,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also modified their holdings of the company. Blue Chip Partners Inc. increased its position in Colgate-Palmolive by 0.4% during the first quarter. Blue Chip Partners Inc. now owns 1,805 shares of the company’s stock worth $132,000 after purchasing an additional 8 shares during the last quarter. Savant Capital LLC increased its position in Colgate-Palmolive by 0.3% during the first quarter. Savant Capital LLC now owns 10,526 shares of the company’s stock worth $770,000 after purchasing an additional 30 shares during the last quarter. Smith Moore & CO. increased its position in Colgate-Palmolive by 0.3% during the first quarter. Smith Moore & CO. now owns 10,373 shares of the company’s stock worth $759,000 after purchasing an additional 32 shares during the last quarter. Front Street Capital Management Inc. increased its position in Colgate-Palmolive by 0.4% during the first quarter. Front Street Capital Management Inc. now owns 8,586 shares of the company’s stock worth $628,000 after purchasing an additional 32 shares during the last quarter. Finally, Jackson Grant Investment Advisers Inc. increased its position in Colgate-Palmolive by 0.5% during the first quarter. Jackson Grant Investment Advisers Inc. now owns 6,993 shares of the company’s stock worth $512,000 after purchasing an additional 37 shares during the last quarter. Institutional investors and hedge funds own 73.16% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This piece of content was reported by Markets Daily and is the property of of Markets Daily. If you are accessing this piece of content on another site, it was illegally stolen and republished in violation of US and international copyright & trademark legislation. The legal version of this piece of content can be viewed at https://www.themarketsdaily.com/2017/09/10/colgate-palmolive-company-cl-position-maintained-by-glenmede-trust-co-na.html.

Colgate-Palmolive Company (CL) traded up 0.36% on Friday, hitting $71.82. 2,952,611 shares of the stock were exchanged. The company has a market cap of $63.26 billion, a PE ratio of 26.69 and a beta of 0.80. The company’s 50-day moving average is $71.66 and its 200-day moving average is $73.33. Colgate-Palmolive Company has a 52 week low of $63.43 and a 52 week high of $77.27.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, July 21st. The company reported $0.72 earnings per share for the quarter, meeting the Zacks’ consensus estimate of $0.72. Colgate-Palmolive had a return on equity of 3,121.95% and a net margin of 15.83%. The business had revenue of $3.83 billion for the quarter, compared to the consensus estimate of $3.89 billion. During the same period last year, the business earned $0.70 EPS. The firm’s revenue was down .5% compared to the same quarter last year. On average, analysts predict that Colgate-Palmolive Company will post $2.89 earnings per share for the current year.

In other Colgate-Palmolive news, CFO Dennis J. Hickey sold 73,872 shares of the firm’s stock in a transaction that occurred on Thursday, August 3rd. The stock was sold at an average price of $71.80, for a total value of $5,304,009.60. Following the sale, the chief financial officer now owns 484,985 shares of the company’s stock, valued at approximately $34,821,923. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, COO Justin Skala sold 74,374 shares of the firm’s stock in a transaction that occurred on Thursday, July 27th. The shares were sold at an average price of $72.51, for a total value of $5,392,858.74. Following the completion of the sale, the chief operating officer now directly owns 97,177 shares in the company, valued at approximately $7,046,304.27. The disclosure for this sale can be found here. Insiders sold a total of 221,802 shares of company stock worth $15,983,976 over the last three months. 1.02% of the stock is owned by company insiders.

Several research firms recently issued reports on CL. Jefferies Group LLC restated a “hold” rating and set a $79.00 price objective on shares of Colgate-Palmolive in a research report on Thursday, August 24th. Zacks Investment Research lowered shares of Colgate-Palmolive from a “hold” rating to a “sell” rating in a research note on Thursday, July 27th. Deutsche Bank AG reaffirmed a “hold” rating and set a $75.00 target price on shares of Colgate-Palmolive in a research note on Monday, July 24th. Wells Fargo & Company reissued a “market perform” rating on shares of Colgate-Palmolive in a research note on Monday, July 24th. Finally, BidaskClub lowered shares of Colgate-Palmolive from a “sell” rating to a “strong sell” rating in a research note on Wednesday, July 12th. Two investment analysts have rated the stock with a sell rating, twelve have issued a hold rating and two have assigned a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus target price of $75.82.

Colgate-Palmolive Profile

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply